JCB, Volume 9, Number 3, 2003 Editorial Vol.9 No. 3 (2003) Editorial: Best practices in communicating biotechnology Anthony J Russo   Commentary Vol.9 No. 3 (2003) Comment: The UK Government's strategic approach to the biotechnology industry Lord Sainsbury The UK Government recognises that biotechnology is a key industry for the future and is determined to create the best possible conditions to continue the sector’s growth and success. Article Vol.9 No. 3 (2003) The ethics of patenting DNA Michael J Reiss Should DNA be patented? This paper argues that the patenting of DNA (whether of human or other origin) is in general acceptable and should be regulated by the same rule Article Vol.9 No. 3 (2003) Recent developments in US law: Remedies and damages for improper patent listings in the FDA's Orange Book Daniel G Brown The Drug Price Competition and Patent Term Restoration Act (Publ. No. 98-417, 98 Stat. 1585 (1984)), commonly known as the Hatch–Waxman Act (the Act) provides th Article Vol.9 No. 3 (2003) Spinning off, cashing up and branching out: Commercialisation considerations for bioentrepreneurs in Australasia Nick Wells There are myriad issues to consider when commercialising a biotechnological innovation. In Australia, because of market structure, the tendency for biotechnology compan Article Vol.9 No. 3 (2003) Biotechnology education in Europe Vivian Moses This study was not intended as a catalogue, but as a comparative overview of the range of opportunities for education in biotechnology open to citizens in the various m Article Vol.9 No. 3 (2003) Database protection in the UK and the USA: What, if any, protection might those who work so hard receive? Robin M C Nott This paper discusses the nature and extent of protection afforded under UK and US laws for sequence listings, with an emphasis on databases containing sequence listings Article Vol.9 No. 3 (2003) Early stage and seed financing for biotechnology start-ups: A UK perspective George Whitehead It is a tough climate in which to be raising early stage investment but there is funding available for the very best of British biotechnology. This report outlines seve Article Vol.9 No. 3 (2003) Legal issues in bioinformatics Caroline McCubbin This paper is a review of legal issues in the discipline of bioinformatics. It covers the intellectual property rights (IPR) protection available to databases (together Legal and Regulatory Updates Vol.9 No. 3 (2003) Legal and regulatory update John Wilkinson   Legal and Regulatory Updates Vol.9 No. 3 (2003) EU Financial accounts reports David Citron  Â
